
Cancer Research Horizons
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Cancer Research Horizons (CRT) develops and commercialises exciting new discoveries in cancer research.
Investor Profile
Cancer Research Horizons has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 11% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Health Care, Biotechnology, Therapeutics.
Stage Focus
- Seed (67%)
- Series A (11%)
- Pre Seed (11%)
- Series Unknown (11%)
Country Focus
- United Kingdom (89%)
- United States (11%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Medical
- Life Science
- Medical Device
- Artificial Intelligence (Ai)
- Clinical Trials
- Wellness
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Cancer Research Horizons frequently co-invest with?
Which angels does Cancer Research Horizons often collaborate with?
What are some of recent deals done by Cancer Research Horizons?
Find More Investors Like Cancer Research Horizons
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides







